In Vitro and In Vivo Experimental Activities of Antifungal Agents against Fusarium solani
Open Access
- 1 May 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (5) , 1256-1257
- https://doi.org/10.1128/aac.43.5.1256
Abstract
In the treatment of disseminated Fusarium infections, amphotericin B either alone or in combination with flucytosine and rifampin is the drug therapy most frequently used. The efficacy of these antifungal drugs was evaluated in a murine disseminated-infection model, with five strains of Fusarium solani . All the treatments were clearly ineffective.Keywords
This publication has 12 references indexed in Scilit:
- In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strainsJournal of Antimicrobial Chemotherapy, 1997
- Opportunistic fusarial infections in humansEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformansAntimicrobial Agents and Chemotherapy, 1995
- In vitro Sensitivity of Medically Significant Fusarium Species to Various AntimycoticsChemotherapy, 1994
- Clinical Use of Amphotericin B and Derivatives: Lore, Mystique, and FactClinical Infectious Diseases, 1992
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution methodAntimicrobial Agents and Chemotherapy, 1989
- The Emerging Role of Fusarium Infections in Patients with CancerMedicine, 1988
- In Vitro Antibiotic Synergism Against Ocular Fungal IsolatesAmerican Journal of Ophthalmology, 1978
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978